Bryan A. Roecklein, Ph.D

Vice President of Corporate Development

Bryan A. Roecklein, Ph.D, joined in July 2015 as our Vice President of Corporate Development. Most recently he was a member of the US Executive Team at Meda Pharmaceuticals leading the Corporate Development function. Prior to that, he was Vice President of Marketing and Business Development, with responsibilities covering Marketing, Access, Trade and Acquisition Strategy. From 2001 to 2011, at MedPointe, then Meda Pharmaceuticals (2007) Dr. Roecklein held various positions with increasing responsibility in Portfolio Management, New Product Planning, Marketing, Medical Education and Commercial Development. From 1998 to 2001, Dr. Roecklein led commercial development at Kimeragen and Valigen and from 1995-1998, he was an independent Investigator at the Fred Hutchinson Cancer Research Center.

Dr. Roecklein earned his B.S. from University of Maryland, College Park and Ph.D in Molecular, Cellular, Developmental Biology from Colorado University, Boulder.